Jennifer Ma

1.9k total citations
54 papers, 817 citations indexed

About

Jennifer Ma is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Jennifer Ma has authored 54 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Jennifer Ma's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer Genomics and Diagnostics (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Jennifer Ma is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer Genomics and Diagnostics (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Jennifer Ma collaborates with scholars based in United States, Canada and China. Jennifer Ma's co-authors include Nancy Y. Lee, Nadeem Riaz, Simon N. Powell, Jeremy Setton, Benjamin H. Lok, Ghassan K. Abou‐Alfa, Marinela Capanu, Eileen M. O’Reilly, Joanne F. Chou and J. Laird and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Jennifer Ma

42 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Ma United States 14 321 253 185 180 169 54 817
Ariane Aigelsreiter Austria 18 222 0.7× 252 1.0× 143 0.8× 52 0.3× 90 0.5× 43 741
Pietro Mingazzini Italy 17 347 1.1× 156 0.6× 187 1.0× 302 1.7× 186 1.1× 54 934
Hye Won Lee South Korea 16 189 0.6× 468 1.8× 387 2.1× 90 0.5× 110 0.7× 78 964
Scott R. Gerst United States 21 344 1.1× 258 1.0× 113 0.6× 629 3.5× 469 2.8× 47 1.4k
Gregory F. Sterrett Australia 20 329 1.0× 181 0.7× 284 1.5× 283 1.6× 216 1.3× 44 1.0k
Jacob R. Izbicki Germany 18 576 1.8× 284 1.1× 257 1.4× 394 2.2× 357 2.1× 47 1.3k
Jae Yeon Seok South Korea 15 149 0.5× 151 0.6× 131 0.7× 278 1.5× 171 1.0× 42 910
Peter Schirmacher Germany 15 188 0.6× 193 0.8× 63 0.3× 173 1.0× 146 0.9× 52 723
Mark Messing United States 13 420 1.3× 261 1.0× 100 0.5× 225 1.3× 171 1.0× 31 1.1k
Hiroomi Tada United States 9 537 1.7× 365 1.4× 146 0.8× 117 0.7× 397 2.3× 13 951

Countries citing papers authored by Jennifer Ma

Since Specialization
Citations

This map shows the geographic impact of Jennifer Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Ma more than expected).

Fields of papers citing papers by Jennifer Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Ma. The network helps show where Jennifer Ma may publish in the future.

Co-authorship network of co-authors of Jennifer Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Ma. A scholar is included among the top collaborators of Jennifer Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Ma. Jennifer Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Anna, Jung Julie Kang, Irini Youssef, et al.. (2025). Updated Estimates of Patients With Oropharyngeal Cancer in the US. JAMA Network Open. 8(10). e2539258–e2539258.
2.
Chen, Monica F., Jennifer Ma, Mark G. Kris, et al.. (2025). Outcomes After Radiation for Oligoprogressive Disease Sites in Patients With EGFR -Mutant Lung Cancer Treated With Osimertinib. JCO Precision Oncology. 9(9). e2500047–e2500047. 1 indexed citations
3.
Balzo, Luke del, et al.. (2024). Artificial-intelligence-driven measurements of brain metastases’ response to SRS compare favorably with current manual standards of assessment. Neuro-Oncology Advances. 6(1). vdae015–vdae015. 5 indexed citations
4.
Ma, Jennifer, Xiangjun Kong, Paula Kroon, et al.. (2024). Non-clinical evaluation of NT-175, an autologous T cell product engineered to express an HLA-A*02:01-restricted TCR targeting TP53 R175H and resistant to TGF-b inhibition.. Journal of Clinical Oncology. 42(16_suppl). 2560–2560.
5.
Ma, Jennifer, Rachna Shah, Andrew Bell, et al.. (2024). Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors. International Journal of Radiation Oncology*Biology*Physics. 121(3). 768–779.
6.
Cederquist, G., Kathryn R. Tringale, Carla Hajj, et al.. (2023). Salvage Radiotherapy as a Bridge for Relapsed Secondary CNS Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 117(2). e459–e459. 1 indexed citations
7.
Ma, Jennifer, Reith Sarkar, G. Cederquist, et al.. (2023). Radiation in a New Era of Multiple Myeloma Management: Patterns of Utilization, Clinical, Radiologic, and Biochemical Outcomes, and Possible Genomic Correlates of Response. International Journal of Radiation Oncology*Biology*Physics. 117(2). S108–S109.
8.
Cederquist, G., Kathryn R. Tringale, Carla Hajj, et al.. (2023). Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma. Blood. 142(Supplement 1). 1759–1759. 1 indexed citations
9.
Wasan, Harpreet, James J. Harding, Jia Fan, et al.. (2023). 101P Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 study. Annals of Oncology. 34. S219–S219. 1 indexed citations
10.
Ma, Jennifer, et al.. (2023). Quality of Life Before and After Radiation Therapy for Early-Stage Keratinocyte Carcinoma: A Longitudinal Analysis. International Journal of Radiation Oncology*Biology*Physics. 117(5). 1090–1095.
11.
Waglechner, Nicholas, Elizabeth Tullis, Anne L. Stephenson, et al.. (2022). Genomic epidemiology of Mycobacterium abscessus in a Canadian cystic fibrosis centre. Scientific Reports. 12(1). 16116–16116. 10 indexed citations
12.
Ma, Jennifer, et al.. (2022). Ethnic/racial differences in risk factors and clinical outcomes among patients with amyloidosis. The American Journal of the Medical Sciences. 365(3). 232–241. 2 indexed citations
13.
Ma, Jennifer, et al.. (2021). Associations between Combined Influenza and Pneumococcal Pneumonia Vaccination and Cardiovascular Outcomes. Cardiology. 146(6). 772–780. 13 indexed citations
14.
Laird, J., Benjamin H. Lok, Jennifer Ma, et al.. (2018). Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts. Clinical Cancer Research. 24(20). 5143–5152. 55 indexed citations
15.
Ma, Jennifer, Benjamin H. Lok, Jingfeng Zong, et al.. (2018). Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot. International Journal of Particle Therapy. 4(4). 10–19. 9 indexed citations
16.
Hirama, Takashi, Alex Marchand‐Austin, Jennifer Ma, et al.. (2018). Mycobacterium xenopi Genotype Associated with Clinical Phenotype in Lung Disease. Lung. 196(2). 213–217. 6 indexed citations
17.
Ma, Jennifer, Jeremy Setton, Nancy Y. Lee, Nadeem Riaz, & Simon N. Powell. (2018). The therapeutic significance of mutational signatures from DNA repair deficiency in cancer. Nature Communications. 9(1). 3292–3292. 148 indexed citations
18.
Laird, J., Jennifer Ma, Karen Chau, et al.. (2017). Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement. International Journal of Radiation Oncology*Biology*Physics. 100(3). 670–678. 12 indexed citations
19.
Lok, Benjamin H., Jennifer Ma, Amanda Foster, et al.. (2017). Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. Advances in Radiation Oncology. 2(4). 548–554. 30 indexed citations
20.
Abou‐Alfa, Ghassan K., Marinela Capanu, Eileen M. O’Reilly, et al.. (2013). A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. Journal of Hepatology. 60(2). 319–324. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ariane Aigelsreiter Breakdown of academic impact, for papers by Pietro Mingazzini Breakdown of academic impact, for papers by Hye Won Lee Breakdown of academic impact, for papers by Scott R. Gerst Breakdown of academic impact, for papers by Gregory F. Sterrett Breakdown of academic impact, for papers by Jacob R. Izbicki Breakdown of academic impact, for papers by Jae Yeon Seok Breakdown of academic impact, for papers by Peter Schirmacher Breakdown of academic impact, for papers by Mark Messing Breakdown of academic impact, for papers by Hiroomi Tada
Rankless by CCL
2026